Longevity Research

Longevity Peptide Research: Epitalon, MOTS-c, and Tesamorelin

2026-09-08·Educational reference

This educational article explores the current landscape of longevity peptide research, with a particular focus on Epitalon and MOTS-c. These peptides have garnered significant attention in the scientific community for their potential roles in modulating various processes associated with aging. While the primary focus remains on these two compounds, we will also briefly touch upon the broader context of research peptides in longevity, including recent findings pertinent to the tesamorelin research peptide, to provide a comprehensive overview of this dynamic field. Researchers and informed laboratory readers will find a detailed examination of their mechanisms of action, evidence from pre-clinical studies, and a discussion of the ongoing research questions that continue to shape our understanding of biological aging.

## What are Longevity Peptides: Epitalon and MOTS-c?

Longevity peptides are a diverse class of short protein fragments that have been identified as potential modulators of cellular and systemic processes linked to aging and age-related decline. Their appeal lies in their specificity and the potential for targeted interventions. Within this expanding field, Epitalon and MOTS-c stand out due to their distinct mechanisms and the breadth of research investigating their effects across various models.

### Epitalon: A Synthetic Tetrapeptide and Telomerase Activator

Epitalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide derived from the naturally occurring pineal gland polypeptide epithalamin. It was first synthesized in Russia in the 1980s by Professor Vladimir Khavinson. Its research interest primarily stems from its reported ability to influence the activity of telomerase, an enzyme responsible for maintaining telomere length, which are protective caps at the ends of chromosomes. Telomere shortening is a well-established hallmark of cellular aging and is associated with various age-related pathologies. The literature suggests Epitalon acts by interacting with specific DNA regions, thereby upregulating telomerase activity, which could theoretically lead to telomere extension in dividing cells.

### MOTS-c: A Mitochondrial-Derived Regulator of Metabolism

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) is a 16-amino acid peptide that originates from the mitochondrial genome, specifically from the mitochondrial 12S rRNA gene. This unique origin distinguishes it from classical nuclear-encoded peptides. Research indicates that MOTS-c plays a crucial role in cellular metabolic homeostasis, primarily by influencing insulin sensitivity and glucose metabolism. It is considered a 'mitochondrial-derived peptide' (MDP), a group of peptides increasingly recognized for their diverse biological functions beyond the mitochondrion itself. Studies suggest MOTS-c acts as a mitokine, signaling from mitochondria to the nucleus and other cellular compartments to regulate metabolic pathways. Its potential implications for longevity research are tied to its ability to modulate metabolic health, a cornerstone of healthy aging.

## Mechanisms of Action: How Epitalon and MOTS-c Influence Cellular Processes

The mechanisms by which Epitalon and MOTS-c exert their observed effects are distinct, yet both converge on fundamental processes relevant to aging. Understanding these pathways is critical for appreciating their potential in longevity research.

### Epitalon's Influence on Telomeres and Gene Expression

The primary proposed mechanism for Epitalon involves its interaction with telomeres and the enzyme telomerase. Telomerase is a ribonucleoprotein reverse transcriptase that adds specific DNA sequence repeats (TTAGGG) to the 3' end of telomeres. In most somatic cells, telomerase activity is low or undetectable, leading to progressive telomere shortening with each cell division, a phenomenon known as the Hayflick limit. This shortening eventually triggers cellular senescence or apoptosis. Epitalon is hypothesized to reactivate or upregulate telomerase activity, thereby potentially stabilizing or even lengthening telomeres in various cell types. This effect has been observed in studies on human fibroblasts and lymphocytes, where Epitalon treatment led to increased telomerase activity and proliferation capacity.

Beyond telomerase, research suggests Epitalon may also influence gene expression related to cellular repair, antioxidant defenses, and circadian rhythms. For instance, studies have indicated its capacity to modulate the expression of genes involved in cell cycle regulation and stress response pathways. This broader impact on cellular resilience and adaptation could contribute to its reported anti-aging effects, suggesting a multi-faceted influence on cellular homeostasis.

### MOTS-c and Metabolic Homeostasis

MOTS-c operates primarily as a regulator of metabolic pathways, particularly those related to glucose and lipid metabolism. Its actions are largely mediated through its interaction with the AMPK (AMP-activated protein kinase) pathway, a master regulator of cellular energy homeostasis. Activation of AMPK typically promotes catabolic processes like glucose uptake and fatty acid oxidation, while inhibiting anabolic processes like lipid synthesis. MOTS-c has been shown to activate AMPK in various cell types, including skeletal muscle cells and hepatocytes.

One key finding is MOTS-c's ability to enhance insulin sensitivity. In models of insulin resistance, MOTS-c treatment improved glucose utilization in skeletal muscle and reduced hepatic glucose production. This suggests a direct role in combating metabolic dysfunction, a common feature of aging and a risk factor for numerous age-related diseases. Furthermore, MOTS-c has been implicated in mitochondrial biogenesis, the process by which new mitochondria are formed. By promoting healthier and more abundant mitochondria, MOTS-c could enhance cellular energy production and reduce oxidative stress, both of which are critical for maintaining cellular function throughout the lifespan. Its influence extends to adipocyte biology, where it may modulate lipid accumulation and inflammation.

## What the Research Shows: Pre-Clinical Evidence and Study Types

The scientific literature supporting the potential of Epitalon and MOTS-c predominantly stems from pre-clinical studies, including *in vitro* cell culture experiments and *in vivo* animal models. These studies provide foundational insights into their biological activities and potential applications.

### Epitalon Research Findings (1990s - Present)

Early research on Epitalon, largely originating from Russian scientific groups, focused on its impact on aging biomarkers. Studies from the 1990s and early 2000s reported that Epitalon could increase lifespan in various animal models, including fruit flies and rodents. For example, a long-term study on rats demonstrated that Epitalon administration led to a significant increase in average lifespan and a decrease in spontaneous tumor incidence (Khavinson et al., 2003). These findings were often attributed to its purported telomerase-activating properties.

**Key Findings in Epitalon Research:**

* **Telomere Maintenance:** *In vitro* studies using human fibroblasts and lymphocytes have shown that Epitalon can induce telomerase activity, leading to the preservation of telomere length and increased cellular replicative capacity (Khavinson et al., 2004). This suggests a potential role in counteracting cellular senescence. * **Antioxidant Effects:** Research indicates Epitalon can enhance antioxidant enzyme activity, such as superoxide dismutase and glutathione peroxidase, thereby reducing oxidative stress in various tissues (Anisimov et al., 2011). This protective effect against reactive oxygen species is crucial for mitigating age-related cellular damage. * **Circadian Rhythm Regulation:** Epitalon has been studied for its potential to restore age-disrupted circadian rhythms, particularly in pineal and adrenal gland functions (Khavinson et al., 2001). This aspect is significant given the strong link between circadian dysregulation and age-related pathologies. * **Neuroprotective Effects:** Some studies in animal models have suggested neuroprotective properties, with Epitalon potentially improving cognitive function and reducing neurodegeneration markers in aged animals (Khavinson et al., 2014).

### MOTS-c Research Findings (2015 - Present)

Research on MOTS-c is more recent, with significant breakthroughs occurring since its discovery in 2015. The focus has primarily been on its metabolic and anti-diabetic effects.

**Key Findings in MOTS-c Research:**

* **Insulin Sensitization:** A seminal study demonstrated that MOTS-c improved glucose homeostasis and insulin sensitivity in diet-induced obese and genetically obese mouse models (Lee et al., 2015). It achieved this by promoting glucose uptake in skeletal muscle and reducing glucose production in the liver. * **Exercise Mimetic Properties:** MOTS-c has been described as an 'exercise mimetic' because it activates metabolic pathways similar to those triggered by physical activity, particularly AMPK (Awuah et al., 2021). This suggests its potential to confer some benefits of exercise in contexts where physical activity is limited. * **Mitochondrial Biogenesis and Function:** Research indicates that MOTS-c can promote mitochondrial biogenesis and improve mitochondrial respiratory function in skeletal muscle cells (Kumagai et al., 2017). Enhanced mitochondrial health is directly linked to cellular vitality and longevity. * **Protection Against Metabolic Stress:** Studies have shown that MOTS-c can protect cells from various metabolic stressors, including high glucose and oxidative stress, by modulating inflammatory responses and improving cellular resilience (Du et al., 2021). * **Neuroprotective and Cardiovascular Effects:** Emerging research is exploring its potential roles beyond metabolism, including neuroprotection in models of Alzheimer's disease and cardiovascular benefits by improving endothelial function (Kim et al., 2022).

## Comparisons and Broader Context: Epitalon vs. MOTS-c and the Tesamorelin Research Peptide

While both Epitalon and MOTS-c are investigated for their longevity-modulating potential, their primary targets and mechanisms are distinct, offering complementary avenues for research. Furthermore, placing them within the broader landscape of research peptides for healthy aging, including the tesamorelin research peptide, provides a more complete picture.

### Epitalon and MOTS-c: Complementary Roles in Longevity Research

Epitalon primarily addresses the cellular hallmarks of aging related to genomic instability and telomere attrition, while MOTS-c focuses on metabolic dysfunction, a key contributor to age-related disease. This distinction suggests that they might address different facets of the aging process, potentially offering synergistic benefits if researched together.

### Tesamorelin Research Peptide: A Broader View of Longevity

The tesamorelin research peptide, a synthetic analogue of growth hormone-releasing hormone (GHRH), represents another class of peptides being explored in the context of healthy aging. While its primary clinical applications have historically centered on managing visceral adipose tissue in HIV-associated lipodystrophy, researchers are investigating its broader physiological roles.

Research on the tesamorelin research peptide typically focuses on its ability to stimulate endogenous growth hormone (GH) secretion from the pituitary gland. GH plays a crucial role in body composition, metabolism, and bone density. In the context of aging, natural GH levels decline, a phenomenon known as somatopause. Research explores whether restoring GH levels through tesamorelin research peptide administration could mitigate some age-related changes, such as reductions in lean muscle mass, increases in adiposity, and declines in bone mineral density. Studies have investigated its effects on body composition, cognitive function, and cardiovascular risk factors in older populations, suggesting potential benefits related to sarcopenia and metabolic health. It's important to note that GH axis modulation is a complex area, and further research is needed to fully understand the long-term implications and appropriate applications of the tesamorelin research peptide in healthy aging contexts.

Comparing these peptides highlights the diverse strategies being investigated in longevity research:

* **Epitalon:** Genomic and cellular integrity (telomeres, DNA repair). * **MOTS-c:** Metabolic regulation and mitochondrial health. * **Tesamorelin research peptide:** Hormonal balance and body composition.

Each offers a unique approach to addressing different facets of the aging phenotype, underscoring the multi-factorial nature of the aging process.

## Open Research Questions and Evidence Gaps

Despite promising pre-clinical findings, significant open questions and evidence gaps remain for both Epitalon and MOTS-c, as well as for the broader category of longevity peptides. Addressing these is crucial for advancing the field.

### For Epitalon:

1. **Mechanistic Elucidation:** While telomerase activation is a prominent theory, the precise molecular targets and signaling pathways through which Epitalon exerts all its observed effects are not fully mapped. Further investigation into its direct interaction with DNA, gene regulatory elements, and other cellular machinery is warranted. 2. **Bioavailability and Pharmacokinetics:** Comprehensive data on Epitalon's pharmacokinetics, including its absorption, distribution, metabolism, and excretion in diverse models, is limited. This information is critical for understanding its effective concentration at target tissues and for informing future research designs. 3. **Long-Term Effects and Safety Profiles:** Most studies are relatively short-term. Long-term studies in various animal models are needed to fully assess its effects on cumulative damage, pathology development, and overall healthspan, alongside any potential off-target or adverse effects over extended periods. 4. **Species Specificity:** The extent to which findings from rodent or *in vitro* models translate directly to more complex biological systems requires further investigation.

### For MOTS-c:

1. **Receptor Identification:** The specific cell surface receptor(s) through which MOTS-c exerts its effects remain largely unidentified. Pinpointing these receptors would provide a clearer understanding of its signaling cascade and allow for the development of more targeted research tools. 2. **Tissue-Specific Actions:** While MOTS-c is known to affect skeletal muscle and liver, a detailed understanding of its actions in other metabolically active tissues (e.g., adipose tissue, brain, pancreas) is still emerging. Its systemic effects and organ crosstalk require further mapping. 3. **Endogenous Regulation:** How endogenous MOTS-c levels are regulated under various physiological and pathological conditions (e.g., exercise, fasting, obesity, aging) is not fully understood. This knowledge could reveal mechanisms for modulating its levels naturally. 4. **Interaction with Other MDPs:** MOTS-c is one of several mitochondrial-derived peptides. Understanding its potential interactions or redundancy with other MDPs (e.g., Humanin, SHLP2) could reveal complex regulatory networks.

### General Gaps for Longevity Peptides, including Tesamorelin Research Peptide:

* **Translational Research:** The leap from promising pre-clinical results to well-controlled, larger-scale studies in more complex models remains a significant hurdle. Rigorous and standardized experimental designs are essential. * **Biomarker Identification:** Developing reliable and validated biomarkers of aging that can accurately assess the efficacy of longevity interventions in a robust manner is an ongoing challenge. * **Combination Therapies:** The aging process is multi-factorial. Research on how these peptides might interact with each other or with other known longevity interventions (e.g., caloric restriction, rapamycin) is largely unexplored but holds significant promise. * **Fundamental Aging Biology:** Deeper understanding of the fundamental mechanisms of aging itself will continue to inform and refine the development of targeted longevity peptides. The tesamorelin research peptide, for example, is impacted by the broader understanding of growth hormone axis regulation in aging.

Addressing these gaps will be instrumental in advancing the understanding and potential utility of these fascinating compounds in the quest for healthy aging.

## Risks and Evidence Gaps for Research Peptides

While the potential benefits of longevity research peptides like Epitalon and MOTS-c are compelling, it is crucial for researchers to acknowledge and thoroughly investigate associated risks and persistent evidence gaps. The scientific rigor applied to these investigations ensures a balanced understanding of their utility.

### General Risks in Peptide Research:

1. **Off-Target Effects:** Peptides, despite their specificity, can sometimes interact with unintended receptors or pathways, leading to unforeseen biological consequences. Comprehensive *in vitro* screening and *in vivo* pharmacology are necessary to identify such interactions. 2. **Immunogenicity:** As exogenous proteins or synthetic analogues, some peptides can elicit an immune response, leading to antibody formation that might neutralize their effects or trigger adverse reactions. This is a common consideration in the development of any peptide-based compound. 3. **Stability and Delivery Challenges:** Peptides are often susceptible to enzymatic degradation and may have poor bioavailability, requiring specific delivery mechanisms or modifications to enhance their stability and efficacy. This can impact experimental design and interpretation. 4. **Dose-Response Relationships:** Establishing precise dose-response curves and optimal administration frequencies in various models can be challenging. An inadequate or excessive dose might fail to produce the desired effect or lead to unintended outcomes. 5. **Long-Term Systemic Impacts:** Many longevity peptides aim for sustained effects over long periods. The long-term systemic impact on diverse physiological systems, beyond the primary target, needs extensive evaluation to rule out chronic adverse effects.

### Specific Evidence Gaps for Epitalon:

* **Replication of Lifespan Studies:** While early studies reported lifespan extension, independent replication of these findings in diverse and genetically heterogeneous animal models, under standardized conditions, is important for strengthening the evidence base. * **Impact on Tumorigenesis:** Some research suggests Epitalon may reduce spontaneous tumor incidence. However, the direct interaction between telomerase activation and cancer risk is a complex and highly debated topic. While telomerase activation in somatic cells can be beneficial for longevity, uncontrolled telomerase activity is a hallmark of many cancers. Rigorous long-term studies are needed to understand how Epitalon specifically influences tumorigenesis in different tissue types and its overall risk-benefit profile regarding cancer development. * **Molecular Specificity:** The exact binding sites and the complete cascade of events leading to telomerase activation are still not fully resolved, necessitating further mechanistic studies.

### Specific Evidence Gaps for MOTS-c:

* **Pharmacodynamics in Different Physiological States:** While MOTS-c shows promise in models of metabolic dysfunction, its precise pharmacodynamic profile in healthy, aged, or disease-specific models requires more detailed mapping. How its effects might differ based on existing metabolic status is an open question. * **Role in Energy Expenditure:** While MOTS-c improves glucose utilization, its direct impact on overall energy expenditure and thermogenesis needs further clarification. This could influence its role in weight management and metabolic health in different contexts. * **Cross-Organ Communication:** Understanding how MOTS-c signals between different organs (e.g., muscle, liver, brain, adipose tissue) and integrates with other hormonal and metabolic signals is a crucial area for future research.

### Gaps Related to the Tesamorelin Research Peptide in Longevity:

* **Long-term Safety in Healthy Aging:** While the tesamorelin research peptide has a known safety profile in specific clinical populations, its long-term effects, especially concerning potential risks like glucose intolerance or tumor growth, when administered to generally healthy aging individuals, are not fully established. Modulating the GH/IGF-1 axis requires careful consideration due to its complex and sometimes paradoxical relationship with longevity pathways. * **Optimal Dosing Regimens for Longevity:** The optimal dosing strategy for maximizing potential healthspan benefits while minimizing risks in an aging context is still an area of active research. Existing protocols may not be directly transferable. * **Precise Impact on Frailty and Cognitive Decline:** While GH can influence muscle and body composition, its direct and consistent impact on complex aging phenotypes like frailty, physical function, and cognitive decline needs further robust investigation in appropriate models.

It is imperative that all research into these peptides proceeds with a cautious, evidence-first approach, prioritizing detailed mechanistic understanding and comprehensive safety assessments in various experimental models before any broader translational considerations are entertained. The scientific community must ensure that the pursuit of longevity is grounded in robust data and a thorough understanding of potential risks.

## Practical Laboratory Considerations for Research Peptides

Working with research peptides like Epitalon, MOTS-c, and the tesamorelin research peptide in a laboratory setting requires careful attention to several practical considerations to ensure experimental integrity and reproducibility.

### Peptide Handling and Storage:

* **Purity Verification:** Always request and review a Certificate of Analysis (CoA) from the supplier, ensuring the peptide's purity (typically >95% for research) and identity (e.g., by mass spectrometry). Impurities can significantly alter experimental outcomes. * **Storage Conditions:** Lyophilized peptides should be stored desiccated at -20°C or -80°C to prevent degradation. Exposure to moisture, light, and elevated temperatures should be minimized. * **Reconstitution:** Reconstitute peptides just before use whenever possible. Use appropriate solvents (e.g., sterile water, PBS, acetic acid) as recommended by the supplier or based on peptide solubility properties. For long-term storage of reconstituted stock solutions, aliquot into small volumes and freeze at -20°C or -80°C to avoid repeated freeze-thaw cycles, which can lead to degradation. * **Sterility:** For *in vitro* cell culture or *in vivo* animal studies, ensure that peptides are reconstituted with sterile, endotoxin-free solutions to prevent contamination.

### Experimental Design and Controls:

* **Dose-Response Studies:** Conduct preliminary dose-response experiments to identify the optimal concentration range that elicits the desired biological effect without causing toxicity. This is particularly relevant for the tesamorelin research peptide due to its hormonal activity. * **Vehicle Controls:** Always include appropriate vehicle controls (e.g., the solvent used for reconstitution) to differentiate peptide-specific effects from solvent-related influences. * **Positive Controls:** Incorporate known positive controls to validate the assay system and ensure its sensitivity to the biological process being investigated. * **Time Course Experiments:** Evaluate the temporal dynamics of peptide action by conducting time course studies, especially for peptides with potential long-term effects like Epitalon. * **Route of Administration:** For *in vivo* models, carefully consider the route of administration (e.g., subcutaneous, intraperitoneal, intravenous) and its impact on bioavailability and tissue distribution. The chosen route must be consistent and justified.

### Analytical Techniques:

* **Confirmation of Peptide Presence:** If possible, use analytical techniques like HPLC or mass spectrometry to confirm the stability and presence of the peptide in your experimental samples, particularly after long-term incubation or *in vivo* administration. * **Measurement of Biological Endpoints:** Utilize robust and validated assays to measure relevant biological endpoints (e.g., telomere length for Epitalon, glucose uptake for MOTS-c, body composition for tesamorelin research peptide). Ensure proper statistical analysis of data. * **Ethical Considerations:** All animal studies must adhere to strict ethical guidelines and receive institutional approval, following the 3Rs principles (Replacement, Reduction, Refinement).

By meticulously adhering to these practical considerations, researchers can enhance the reliability and reproducibility of their studies involving longevity research peptides, contributing to a robust body of scientific evidence.

## FAQ: Longevity Peptide Research

### What is the primary difference between Epitalon and MOTS-c in terms of their anti-aging mechanisms?

Epitalon is primarily understood to exert its effects through the activation of telomerase, thereby influencing telomere length and genomic stability, which are crucial for cellular replicative capacity and delaying senescence. In contrast, MOTS-c functions predominantly as a regulator of metabolic homeostasis, enhancing insulin sensitivity, promoting mitochondrial biogenesis, and influencing glucose and lipid metabolism. While both aim to promote healthy aging, Epitalon targets cellular genomic integrity, and MOTS-c targets metabolic efficiency and mitochondrial health.

### How does the tesamorelin research peptide fit into the broader context of longevity research compared to Epitalon and MOTS-c?

The tesamorelin research peptide, a GHRH analogue, primarily influences longevity research through its ability to stimulate endogenous growth hormone (GH) secretion. This differs from Epitalon's telomerase activation and MOTS-c's metabolic regulation. Tesamorelin research peptide focuses on modulating hormonal balance, particularly the GH/IGF-1 axis, which is known to decline with age and affects body composition, muscle mass, and potentially cognitive function. While Epitalon and MOTS-c address cellular and metabolic hallmarks, tesamorelin research peptide tackles a systemic hormonal aspect of aging.

### Are there any concerns regarding telomerase activation by Epitalon and its potential link to cancer?

This is a critical area of ongoing research. Telomerase activation is generally beneficial for healthy somatic cells to maintain telomere length and avoid senescence. However, uncontrolled telomerase activity is a hallmark of cancer cells, enabling their immortalization. The precise mechanism by which Epitalon modulates telomerase, and whether it could promote tumorigenesis, particularly in cells with existing genetic instability, requires extensive long-term *in vivo* studies. Current research suggests it promotes a balanced regulation, but the scientific community remains cautious and emphasizes rigorous investigation of this potential interaction.

### What are mitochondrial-derived peptides (MDPs), and why is MOTS-c considered one of them?

Mitochondrial-derived peptides (MDPs) are a novel class of peptides encoded by short open reading frames within the mitochondrial genome, distinguishing them from peptides encoded by nuclear DNA. MOTS-c is considered an MDP because it is transcribed from the mitochondrial 12S rRNA gene. These peptides are increasingly recognized as important signaling molecules (mitokines) that mediate communication between mitochondria and other cellular compartments, influencing a wide range of biological processes including metabolism, stress response, and cell survival. Their unique origin and diverse functions make them a fascinating area of longevity research.

### What are the key challenges in translating longevity peptide research from pre-clinical models to broader applications?

Translating longevity peptide research faces several challenges. Firstly, establishing reliable and robust data from well-designed, long-term animal studies that show consistent improvements in healthspan and lifespan is crucial. Secondly, the complexity of aging means that single interventions may not address all aspects, leading to the need for understanding combination therapies. Thirdly, identifying precise biomarkers to measure efficacy and safety in complex systems is difficult. Finally, navigating regulatory pathways and ensuring the absence of long-term adverse effects, particularly for compounds intended for healthy aging, requires extensive and careful investigation, especially for the tesamorelin research peptide with its systemic hormonal effects.

## Conclusion: The Evolving Landscape of Tesamorelin Research Peptide, Epitalon, and MOTS-c

The field of longevity peptide research is dynamic and rapidly advancing, with Epitalon and MOTS-c standing as prominent examples of compounds under intense scientific scrutiny. Epitalon offers a unique avenue through its purported influence on telomerase and genomic stability, while MOTS-c presents a compelling case for metabolic health and mitochondrial function. Both aim to address fundamental hallmarks of aging, offering distinct yet potentially complementary strategies for promoting healthy aging in research models. Furthermore, understanding the broader context, including insights from the tesamorelin research peptide, highlights the diverse approaches being explored to modulate the aging process. The ongoing research into these peptides, from their precise mechanisms of action to their systemic effects and interactions, continues to enrich our understanding of biological aging. The future of longevity research relies on rigorous, evidence-based investigation to fully uncover the potential and limitations of these fascinating compounds.

Educational reference only — in-vitro research use only.

Longevity Peptide Research: Epitalon, MOTS-c, and Tesamorelin

More in Longevity Research

Mitochondrial Peptides: MOTS-c and SS-31 in Longevity Research

Epitalon: The Pineal Peptide in Longevity Research

MOTS-c: The Mitochondrial-Derived Peptide in Metabolic and Longevity Research